Cargando…
The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel–Lindau tumor suppressor
Mutations of the von Hippel–Lindau (pVHL) tumor suppressor are causative of a familiar predisposition to develop different types of cancer. pVHL is mainly known for its role in regulating hypoxia-inducible factor 1 α (HIF-1α) degradation, thus modulating the hypoxia response. There are different pVH...
Autores principales: | Falconieri, Antonella, Minervini, Giovanni, Bortolotto, Raissa, Piovesan, Damiano, Lopreiato, Raffaele, Sartori, Geppo, Pennuto, Maria, Tosatto, Silvio C. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522254/ https://www.ncbi.nlm.nih.gov/pubmed/32985545 http://dx.doi.org/10.1038/s41598-020-72683-3 |
Ejemplares similares
-
Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors
por: Minervini, Giovanni, et al.
Publicado: (2017) -
VHLdb: A database of von Hippel-Lindau protein interactors and mutations
por: Tabaro, Francesco, et al.
Publicado: (2016) -
Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors
por: Minervini, Giovanni, et al.
Publicado: (2019) -
Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein
por: Minervini, Giovanni, et al.
Publicado: (2015) -
Design and Analysis of a Petri Net Model of the Von Hippel-Lindau (VHL) Tumor Suppressor Interaction Network
por: Minervini, Giovanni, et al.
Publicado: (2014)